行情

NTRA

NTRA

Natera
NASDAQ

实时行情|Nasdaq Last Sale

37.64
+0.30
+0.80%
盘后: 37.64 0 0.00% 16:07 01/17 EST
开盘
37.26
昨收
37.34
最高
38.25
最低
37.10
成交量
68.80万
成交额
--
52周最高
40.92
52周最低
12.51
市值
29.18亿
市盈率(TTM)
-20.2409
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NTRA 新闻

  • 去年中国吸收外资1400亿美元 仍是第二大外资流入国
  • 新华社.4小时前
  • 人脸识别技术该不该禁止?谷歌与微软各执一词
  • 新浪科技.4小时前
  • 隔夜要闻:美股周一休市 财报季进入白热化阶段在即
  • 新浪美股.5小时前
  • 供应充足预期冲淡利比亚局势影响 油价微涨
  • 新浪美股.6小时前

更多

所属板块

医疗设备、用品及经销
+0.07%
医疗设备和用品
+0.29%

热门股票

名称
价格
涨跌幅

NTRA 简况

Natera, Inc. is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing, to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother's blood and a blood sample from the alleged father(s).
展开

Webull提供Natera Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。